Rachel C. Stanton

FDA investigator

Appears on 5 documents from 2022 to 2024, mostly at sites in California. Most often cites responsibilities of quality control unit (21 CFR 211.22(a)).

5
Documents on file
7.8
Observations per 483
2022
First seen
2024
Most recent

What they cite most

From 39 observations

Activity by year

2022: 1, 2023: 2, 2024: 2

Where

California 5

Is Rachel C. Stanton coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Noble Panacea Labs, IncNov 8, 2024 · Irvine, California
483 ASC Marketing LTDApr 5, 2024 · Chula Vista, California
483 Central Admixture Pharmacy Services IncAug 25, 2023 · San Diego, California
483 Societal CDMO San Diego, LLCJan 25, 2023 · San Diego, California
483 Advanced Cosmetic Research LaboratoriesApr 27, 2022 · Chatsworth, California

About this profile

What does Rachel C. Stanton inspect?

Rachel C. Stanton appears on 5 documents on file covering 5 sites, mostly in California.

What do they cite most often?

21 CFR 211.22(a) (responsibilities of quality control unit), followed by 21 CFR 211.160(a) and 21 CFR 211.165(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Rachel C. Stanton is dated Nov 8, 2024.